Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new five factor model of schizophrenia

J P Lindenmayer1, R Bernstein-Hyman, S Grochowski

  • 1Psychopharmacology Research Unit, Manhattan Psychiatric Center, Wards Island, New York, NY 10035.

The Psychiatric Quarterly
|January 1, 1994
PubMed
Summary

This study introduces a five-syndrome model for schizophrenia psychopathology, moving beyond the positive-negative approach. This new model better captures individual patient differences in schizophrenia symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tardive dyskinesia versus tardive syndrome. What is in a name?

Parkinsonism & related disorders·2025
Same author

Effects of Clozapine on Neurocognitive Functions in Schizophrenia: A Naturalistic Comparison to Non-clozapine Antipsychotics.

Innovations in clinical neuroscience·2022
Same author

Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia.

Brain stimulation·2018
Same author

The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.

Schizophrenia research·2017
Same author

Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo.

Schizophrenia research·2013
Same author

Long-acting injectable antipsychotics: focus on olanzapine pamoate.

Neuropsychiatric disease and treatment·2010

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Psychopathology Research

Background:

  • Schizophrenic psychopathology is complex and multidimensional.
  • The positive-negative syndrome approach has limitations in capturing the full spectrum of symptoms.
  • Existing methods struggle with mixed syndromes and differentiating primary vs. secondary negative symptoms.

Purpose of the Study:

  • To address limitations of the positive-negative syndrome model in schizophrenia.
  • To propose and validate a more comprehensive five-syndrome model for schizophrenia psychopathology.
  • To provide a nuanced framework for assessing individual patient presentations.

Main Methods:

  • Reanalysis of factor analytic procedures on 240 schizophrenic patients.
  • Utilized data from the Positive and Negative Syndrome Scale (PANSS).
  • Supported by three independent and comparable factor analyses.

Main Results:

  • A five-factor solution emerged as the best fit for psychopathological data.
  • Identified five distinct domains: negative, positive, excitement, cognitive, and depression/anxiety.
  • Demonstrated internal consistency and initial validation of the five factors.

Conclusions:

  • The proposed five-syndrome model offers a more refined approach to understanding schizophrenia.
  • This model better characterizes the unique psychopathological profile of individual patients.
  • The five domains provide a more comprehensive assessment of schizophrenia symptoms.

Related Experiment Videos